These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30378155)

  • 1. Synergistic antitumor effects of rhein and doxorubicin in hepatocellular carcinoma cells.
    Wu L; Liu X; Cao KX; Ni ZH; Li WD; Chen ZP
    J Cell Biochem; 2020 Oct; 121(10):4009-4021. PubMed ID: 30378155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhein reverses doxorubicin resistance in SMMC-7721 liver cancer cells by inhibiting energy metabolism and inducing mitochondrial permeability transition pore opening.
    Wu L; Cao K; Ni Z; Wang S; Li W; Liu X; Chen Z
    Biofactors; 2019 Jan; 45(1):85-96. PubMed ID: 30496631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mitochondrial permeability transition in human hepatocellular carcinoma Hep-G2 cell death induced by rhein.
    Du Q; Bian XL; Xu XL; Zhu B; Yu B; Zhai Q
    Fitoterapia; 2013 Dec; 91():68-73. PubMed ID: 23994628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of a Self-Assembled Rhein-Doxorubicin Nanogel Targeting Mitochondria and Investigation on Its Antihepatoma Activity.
    Wu L; Shi Y; Ni Z; Yu T; Chen Z
    Mol Pharm; 2022 Jan; 19(1):35-50. PubMed ID: 34890210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
    Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
    Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells.
    Wu L; Zhao J; Cao K; Liu X; Cai H; Wang J; Li W; Chen Z
    Cell Commun Signal; 2018 Feb; 16(1):6. PubMed ID: 29402287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells.
    Saha SK; Yin Y; Kim K; Yang GM; Dayem AA; Choi HY; Cho SG
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium.
    Zhang J; Song J; Wu D; Wang J; Dong W
    Med Oncol; 2015 Apr; 32(4):101. PubMed ID: 25737432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
    Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
    Oncotarget; 2014 May; 5(9):2853-63. PubMed ID: 24797310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. III-10, a newly synthesized flavonoid, induces cell apoptosis with the involvement of reactive oxygen species-mitochondria pathway in human hepatocellular carcinoma cells.
    Dai Q; Yin Q; Zhao Y; Guo R; Li Z; Ma S; Lu N
    Eur J Pharmacol; 2015 Oct; 764():353-362. PubMed ID: 26164795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase mediated synergistic effect of Boswellia serrata extract in combination with doxorubicin against human hepatocellular carcinoma.
    Khan MA; Singh M; Khan MS; Najmi AK; Ahmad S
    Biomed Res Int; 2014; 2014():294143. PubMed ID: 25177685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihepatocellular Carcinoma Potential of Tetramethylpyrazine Induces Cell Cycle Modulation and Mitochondrial-Dependent Apoptosis: Regulation of p53 Signaling Pathway in HepG2 Cells In Vitro.
    Bi L; Yan X; Chen W; Gao J; Qian L; Qiu S
    Integr Cancer Ther; 2016 Jun; 15(2):226-36. PubMed ID: 27179035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Fuel Dependence on Glutamine Drives Chemo-Resistance in the Cancer Stem Cells of Hepatocellular Carcinoma.
    Lee ACK; Lau PM; Kwan YW; Kong SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells.
    Li J; Wu DD; Zhang JX; Wang J; Ma JJ; Hu X; Dong WG
    World J Gastroenterol; 2018 May; 24(17):1901-1910. PubMed ID: 29740205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
    Wang C; Wei X; Shao G
    Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic inhibition of metastatic breast cancer by dual-chemotherapy with excipient-free rhein/DOX nanodispersions.
    Wang R; Yang Y; Yang M; Yuan D; Huang J; Chen R; Wang H; Hu L; Di L; Li J
    J Nanobiotechnology; 2020 Aug; 18(1):116. PubMed ID: 32847586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Dahuang zhechong pill on doxorubicin-resistant SMMC-7721 xenografts in mice.
    Wu L; Cao KX; Ni ZH; Li WD; Chen ZP; Cheng HB; Liu X
    J Ethnopharmacol; 2018 Aug; 222():71-78. PubMed ID: 29609009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Ca(2+) Selectively Enhances Adriamycin-induced Cell Death in Human Hepatoma Cells.
    Huang X; Xu Y; Liu Y; Xie H; Wang J; Wu Z
    Curr Cancer Drug Targets; 2015; 15(6):481-92. PubMed ID: 26282547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
    Buondonno I; Gazzano E; Jean SR; Audrito V; Kopecka J; Fanelli M; Salaroglio IC; Costamagna C; Roato I; Mungo E; Hattinger CM; Deaglio S; Kelley SO; Serra M; Riganti C
    Mol Cancer Ther; 2016 Nov; 15(11):2640-2652. PubMed ID: 27466354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.